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Abstract
Aim: We sought to compare the outcomes of patients who underwent an open vs robotic ureteroneocystostomy
for ureteral obstruction.
Methods: Retrospective review was performed on adult patients who underwent primary ureteroneocystostomy
for obstruction from January 2012 to April 2018. Intraoperative outcomes of estimated blood loss (EBL) and
operative time, as well as postoperative outcomes of catheter and stent duration, length of hospital stay,
inpatient nurse-controlled opioid use, patient-controlled analgesia (PCA), and outpatient opioid prescription,
complications, readmission, radiologic and clinical stricture recurrence, and follow-up, were compared. Among
the open cohort, indications for an open approach were evaluated, identifying patients with prior complex open
abdominal surgery that would make an open approach preferable.
Results: Open ureteroneocystostomy was performed in 27 patients compared with 18 who underwent a robotic
approach. The open and robotic cohorts were not significantly different in age, gender, Charlson comorbidity index,
stricture location or side, abdominal surgery (laparoscopic or open), pelvic radiation, or preoperative urinary tract
infection. The robotic group had a significantly lower rate of prior open abdominal surgery. The robotic cohort had
significantly lower EBL, length of stay (LOS), catheter duration, prescribed morphine milliequivalents (MME) at
discharge, and rate of PCA usage. Among the open cohort, 13 (48%) patients demonstrated indications making an
open approach preferable. Comparing the robotic group with the remaining 14 open patients revealed a significantly
lower rate of inpatient PCA use, prescribed MME at discharge, LOS, and catheter duration. Mean operative time
was higher in the robotic group. EBL was not significantly different in this subanalysis.
Conclusions: Robotic ureteroneocystostomy provides similar outcomes when compared with an open approach
in well-selected patients when assessing for recurrent ureteral obstruction or adverse events. Robotic surgery is
associated with lower postoperative narcotic pain prescriptions at discharge, lower PCA usage, and shorter
LOS, which are important benefits when compared with open surgery.
Keywords: ureteroneocystostomy, ureteral stricture, ureteral obstruction, ureteral reconstruction, robotics,
laparoscopy approach
Introduction
Ureteral injury and stricture disease is an uncommonbut morbid condition that often requires complex ure-
teral reconstruction as treatment.1 A definitive surgical option
for repair of ureteral obstruction is ureteroneocystostomy,
which historically was performed via an open approach with
excellent success rates.2 With the availability of minimally
invasive techniques, laparoscopic ureteroneocystostomy has
been described as a feasible approach to managing ureteral
reconstruction.3,4 Studies demonstrate that this approach is
associated with a benefit in terms of hospitalization duration,
intraoperative blood loss, and narcotic pain prescription while
carrying no increased complications compared with the open
approach.3,4
Robotic ureteroneocystostomy has gained popularity
over a standard laparoscopic approach for ureteral sur-
gery due to greater visibility, maneuverability, dexterity,
1University of Michigan Medical School, Ann Arbor, Michigan, USA.
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surgeon ergonomics, and ease of intracorporeal sutur-
ing.5–7 Few studies exist comparing the outcomes of ro-
botic ureteroneocystostomy with an open approach.8 We
sought to compare the intraoperative and postoperative
course of patients who underwent ureteroneocystostomy
via robotic vs an open approach. Multiple factors can in-
fluence a patient’s candidacy for robotic surgery. We also
sought to compare those open surgical patients without a
history of complex open intraperitoneal surgery with robotic
surgery patients. We hypothesized that patients who underwent
robotic surgery would have equivalent outcomes with the po-
tential for improved postoperative convalescence when com-
pared with the open ureteroneocystostomy patients, and that
these conclusions would persist when only comparing robotic
patients with those open patients without a contraindication to a
minimally invasive approach.
Methods
Data and study population
All patients who underwent a ureteroneocystostomy be-
tween January 2012 and March 2018 at a single institution
were identified using billing codes. Of these 646 patients,
598 were excluded from the initial data set. Exclusion cri-
teria were as follows: younger than 18 years, malignancy of
the ureter or bladder, ureteroneocystostomy into a conduit or
neobladder, renal transplant ureteroneocystostomy, history
of complex urologic reconstruction (such as bladder aug-
mentation cystoplasty), Boari flap, intravesical psoas hitch,
bilateral ureteroneocystostomy, or a ureteroneocystostomy
performed in conjunction with another major surgery. Three
patients were converted from a robotic to open approach
intraoperatively: two due to intra-abdominal adhesions, and
one due to poor visualization and failure to progress; these
three patients were also excluded from comparative analysis
(Fig. 1).
Outcomes
After institutional review board (IRB) approval, we per-
formed a retrospective chart review with interest in the
following: patient demographics, Charlson comorbidity in-
dex, side, location, and etiology of obstruction, estimated
blood loss (EBL) and operative time, length of hospital
stay, inpatient nurse-controlled IV and oral opioid use,
patient-controlled analgesia (PCA), and discharge opioid
prescription, days with catheter after surgery, stent duration,
complications, readmission rate, stricture recurrence dem-
onstrated radiologically or need for further instrumentation,
and time to follow-up. Among the open cohort, indications
for an open approach were evaluated, identifying patients
with prior complex open abdominal surgery that would make
an open approach preferable.
Statistical analysis
Statistical analysis was performed using SPSS statistical
software (IBM, Armonk, NY). Open and robotic cohorts
were compared using independent samples parametric t test,
Mann–Whitney U test, and chi-squared test when appropri-
ate, with p-value <0.05 considered statistically significant.
Results
Forty-five patients met the inclusion criteria. Twenty-
seven underwent an open ureteroneocystostomy, and 18
underwent robotic reconstruction. The decision to proceed
with either robotic or open surgery was made by the primary
surgeon. The 27 open patients were performed by 6 urolo-
gists, while the 18 robotic patients were performed by 5
urologists. Of the open cohort, 23 (85.2%) of ureter-
oneocystostomies were performed via midline incision, and 4
(14.8%) were performed via Pfannenstiel incision. Of note,
the open surgery patients had a significantly higher rate of
prior open abdominal surgery, 13 (48.1%) as opposed to 2
(11.1%) in the robotic group. Demographic data are found in
Table 1.
FIG. 1. Exclusion criteria. Six hundred forty-six patients
were identified using CPT codes 50780, 50782, 50783,
50785, 50947, 50948, and 50949. CPT = current procedural
terminology.


















































In the robotic cohort, there was a lower EBL after the
operation, with a median of 50 cc compared with 100 cc
in the open cohort ( p = 0.006). No patients required a blood
transfusion. Patients who underwent a robotic ureteroneo-
cystostomy also had a shorter admission postoperatively,
with the median length of stay (LOS) at 1.5 days, as opposed
to 3 days in the open group ( p < 0.001). Robotic cohort pa-
tients also had a urethral catheter after surgery for a signifi-
cantly shorter time, with a median of 1 day in the robotic
group and 9 days in the open group ( p = 0.001). There
were no significant differences in complication rates as an
inpatient or 30 or 90 days postoperatively. No differences
in readmission rate or stricture recurrence were detected
(Table 2).
Narcotic pain usage of patients as an inpatient as well
as prescription narcotics given at discharge was compared.
Patients who underwent a robotic ureteroneocystostomy
had a significantly lower rate of PCA usage after their op-
eration (5.6% vs 55.6%, p < 0.001). In addition, patients in
the robotic cohort were prescribed an average of 336.4
morphine milliequivalents (MME) of narcotics at discharge,
significantly lower than the open cohort (535.6 MME,
p = 0.032) (Table 2). The groups did not differ significantly
in inpatient nurse-controlled IV and oral narcotic adminis-
tration ( p = 0.18).
Among the open cohort, 14 (52%) patients did not have a
history of complex intraperitoneal abdominopelvic surgery
or absolute contraindication to a minimally invasive ap-
proach. It was presumed that these patients underwent an
open approach based on the preferences of the patient or
surgeon. We compared these 14 patients with the robotic
surgery cohort. Analysis revealed a significantly lower rate of




(n = 18) p
Age (years), mean (SD) 48.3 (14.5) 53.1 (15.2) 0.29
Gender, n (%) 0.46
Male 5 (18.5) 5 (27.8)




0 9 (33.3) 7 (38.9)
1 to 3 12 (44.4) 6 (33.3)
‡4 6 (22.2) 5 (27.8)
Stricture side, n (%) 0.11
Left 14 (51.9) 5 (27.8)




Proximal 0 (0) 0 (0)
Middle/iliac 6 (22.2) 1 (5.6)
Distal 21 (74.1) 17 (94.4)
Prior abdominal surgery,
n (%)
23 (85.2) 13 (72.2) 0.29
Prior open abdominal
surgery, n (%)
13 (48.1) 2 (11.1) 0.01
Prior pelvic radiation,
n (%)
1 (3.7) 1 (5.6) 0.77
Preoperative UTI,
n (%)
8 (29.6) 7 (38.9) 0.57
SD = standard deviation; UTI = urinary tract infection.
Table 2. Results
Open (n = 27) Robotic (n = 18) p
Operative time (minutes), mean (SD) 209.6 (128.6) 195.0 (49.5) 0.65
Inpatient nurse-controlled morphine milliequivalents, mean (SD) 367.0 (304.4) 263.4 (120.5) 0.18
Inpatient use of patient-controlled analgesia, n (%) 15 (55.6) 1 (5.6) <0.001
Prescribed morphine milliequivalents at discharge, mean (SD) 535.6 (352.7) 336.4 (172.3) 0.03
Estimated blood loss (cc), median (range) 100 (25–1300) 50 (10–150) 0.006
Length of stay (days), median (range) 3 (1–11) 1.5 (1–4) <0.001
Catheter duration (days), median (range) 9 (1–26) 1 (1–19) 0.001
Stent duration (days), median (range) 33 (22–119) 31.5 (18–53) 0.59
Clavien–Dindo classification inpatient, n (%) 0.34
No complication 23 17
Grade I to II 4 1
Grade III to IV 0 0
Clavien–Dindo classification 30 days, n (%) 0.44
No complication 19 12
Grade I to II 6 6
Grade III to IV 1 0
Clavien–Dindo classification 90 days, n (%) 0.90
No complication 17 11
Grade I to II 7 6
Grade III to IV 2 1
90-Day readmission, n (%) 7 (26.9) 5 (27.8) 0.71
Stricture recurrence, n (%) 1 (3.7) 0 (0.0) 0.50
Radiologic follow-up (months), mean (SD) 12.1 (13.3) 10.6 (12.1) 0.70
Symptomatic follow-up (months), mean (SD) 19.9 (17.8) 14.1 (14.9) 0.26


















































inpatient PCA use (5.5% vs 35.7%, p = 0.030), prescribed
MME at discharge (336.39 vs 555.71, p = 0.046), LOS (1.5
vs 2, p = 0.004), and urethral catheter duration in days
after surgery (1 vs 9.5, p = 0.002) in the robotic group.
Operative time (minutes) was significantly longer in the ro-
botic group (194.9 vs 157.4 p = 0.022). EBL (cc) was not
significantly different in this analysis (50 vs 50, p = 0.319).
There were no significant differences in complication
rates as an inpatient, or 30 or 90 days postoperatively. No
differences in readmission rate or stricture recurrence were
detected.
Discussion
Robotic ureteroneocystostomy is gaining popularity over
a standard laparoscopic or open approach. In this study, we
compared patients who underwent open ureteroneocysto-
stomy vs those who had a robotic approach and found no
detectable difference in postoperative complications or re-
current obstruction. The robotic group had a shorter LOS,
shorter urethral catheter duration, and lower narcotic pain
prescriptions. When patients who had prior complex open
intraperitoneal surgery making an open approach prefer-
able were excluded from analysis, these findings persisted.
Robotic ureteroneocystostomy is a safe, viable procedure
with comparable outcomes with an open approach.
In our study, patients with ureteral stricture disease who
underwent a robotic ureteroneocystostomy had similar
complication rates and there were no differences in read-
mission rate or stricture recurrence. Potential benefits of
the robotic approach included shorter LOS, lower inpatient
PCA use, and decreased opioid prescriptions at discharge.
A shorter urethral catheter duration was also noted; however,
it is important to state that this could reflect a difference
in practice pattern rather than solely an advantage of a ro-
botic approach. A decreased LOS and improved convales-
cence in the robotic group likely enable the patient to tolerate
an earlier removal of the urethral catheter, but the difference
in catheter duration likely does not reflect any difference in
the quality of the ureteral anastomosis or bladder function
that would require a prolonged urethral catheter in the open
cohort.
Our findings support the current literature on robotic sur-
gery for urologic procedures, including ureteroneocysto-
stomy. Fifer and colleagues9 published a series of 55 patients
who underwent robotic ureteral reconstructive procedures
distal to the ureteropelvic junction. All cases were effectively
completed robotically with no open conversions and no
intraoperative complications. Median blood loss was 50 mL.
The average hospital stay was 1.6 days, with 71% discharged
on postoperative day 1. There were two serious complica-
tions and three failures. Hemal and coworkers6 describe 44
robotic procedures of diverse ureteral pathologies, including
ureteroneocystostomy. Mean blood loss was 98.2 mL (range:
<50–400). There were no urine leaks (range: 1–2.5) and mean
hospital stay was 2.4 days (range: 1–6). Complications in-
cluded one case of sepsis and one antibiotic-induced infec-
tion. Operative success as defined by symptom resolution and
imaging was 100%. These studies, while not a comparative
analysis, support the feasibility of robotic ureteral recon-
struction. We found similar efficacy in the robotic approach
in our study.
Comparative analyses between robotic and open ap-
proaches are subject to selection bias, and our study is no
different. In an attempt to evaluate cohorts that are more
comparable, we identified patients who lacked a strong
contraindication to a robotic approach, in this case prior
complex open intraperitoneal surgery, but were still per-
formed open based on patient and physician preference.
When compared with the robotic cohort, the differences in
LOS, catheter duration, PCA usage, and MME at discharge
persisted, supporting the notion that the approach plays a role
in varied postoperative outcomes, and cannot be solely ex-
plained by open ureteroneocystostomy patients having a
more complex abdomen.
Our study does have several limitations. Our cohort size is
small, and larger studies are required to validate our findings.
This study was retrospective and therefore is subject to several
biases. Aside from stricture location, other factors that con-
tribute to stricture complexity could not be measured and
therefore may confound our results. Although a prospective
randomized trial would provide definitive results, this would be
challenging to perform as there are several factors that influence
the decision to perform this surgery via an open or robotic
approach. Three patients required conversion from robotic to
open, which reveals that a patient’s candidacy for a robotic
ureteroneocystostomy is a complex decision that cannot always
be accounted for by surgical history or radiologic imaging.
Related to this, changing practice patterns at our institution may
have played a role in the surgeon’s decision to operate roboti-
cally, as ureteroneocystostomy was not regularly performed
robotically earlier in the cohort. It is prudent to address the fact
that the differences in postoperative outcomes we observed may
be due to practice patterns at our institution, particularly sur-
rounding catheter duration. However, there was no difference in
complication rates or stricture recurrence, supporting the safety
of a robotic approach and its associated practice patterns.
Conclusion
Robotic surgery for ureteroneocystostomy is a safe, com-
parable alternative to open surgery with similar complication
and failure rates and potential benefits in postoperative
convalescence.
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EBL¼ estimated blood loss
LOS¼ length of stay
MME¼morphine milliequivalents
PCA¼ patient-controlled analgesia
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